Eradication of human immunodeficiency virus from brain reservoirs

被引:0
|
作者
Avindra Nath
机构
[1] National Institutes of Health,Section of Infections of the Nervous System, National Institute of Neurological disorders and Stroke
来源
Journal of NeuroVirology | 2015年 / 21卷
关键词
Compartmentalization; Astrocyte; Microglia; Macrophage; Antiretroviral; Latency;
D O I
暂无
中图分类号
学科分类号
摘要
Isolated cases in which human immunodeficiency virus (HIV) infection was claimed to have been eradicated generated renewed interest in HIV reservoirs in the brain particularly since attempts to reproduce the findings using genetically engineered stem cells and immune- or myeloablation have failed. A clear understanding of the cell types in which the virus resides in the brain, the mechanism of viral persistence, restricted replication and latency, and the turnover rate of the infected cells is critical for us to develop ways to control or get rid of the virus in the brain. The brain has several unique features compared to other reservoirs. There are no resident T cells in the brain; the virus resides in macrophages and astrocytes where the viral infection is non-cytopathic. The virus evolves in the brain and since the turnover rate of these cells is low, the virus has the potential to reside in these cells for several decades and possibly for the life of the individual. This review discusses the HIV reservoirs in the brain, issues related to eradication of the virus from sanctuaries in the brain, and current challenges faced by neuroscientists in finding a cure.
引用
收藏
页码:227 / 234
页数:7
相关论文
共 50 条
  • [31] Pulmonary Innate Immune Dysfunction in Human Immunodeficiency Virus
    Staitieh, Bashar S.
    Egea, Eduardo E.
    Guidot, David M.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 56 (05) : 563 - 567
  • [32] Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1
    Katarzyna Kaźmierczak
    Mary Jane Potash
    Journal of NeuroVirology, 2007, 13 : 452 - 461
  • [33] Neurotoxicity and neuroprotection, two aspects of microglial activation in human immunodeficiency virus (HIV) infection
    Vallat-Decouvelaere, AV
    Gray, F
    Chrétien, F
    Le Pavec, G
    Dormont, D
    Gras, G
    ANNALES DE PATHOLOGIE, 2004, 24 (01) : 31 - 44
  • [34] The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus
    D'Amico, Daniela
    Valdebenito, Silvana
    Eugenin, Eliseo A.
    PURINERGIC SIGNALLING, 2021, 17 (04) : 563 - 576
  • [35] The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus
    Daniela D’Amico
    Silvana Valdebenito
    Eliseo A. Eugenin
    Purinergic Signalling, 2021, 17 : 563 - 576
  • [36] Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research
    Bauer, Anya M.
    Ziani, Widade
    Lindemuth, Emily
    Kuri-Cervantes, Leticia
    Li, Hui
    Lee, Fang-Hua
    Watkins, Meagan
    Ding, Wenge
    Xu, Huanbin
    Veazey, Ronald
    Bar, Katharine J.
    JOURNAL OF VIROLOGY, 2020, 94 (08)
  • [37] HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites
    Saksena, Nitin K.
    Wang, Bin
    Zhou, Li
    Soedjono, Maly
    Ho, Yung Shwen
    Conceicao, Viviane
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 103 - 122
  • [38] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [39] Switching Human Immunodeficiency Virus Therapy Basic Principles and Options
    Lima, Danilo Bacic
    Solomon, Daniel A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 409 - 422
  • [40] COFACTORS IN THE LATENCY AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
    CUNNINGHAMRUNDLES, S
    HILGARTNER, MW
    TARTER, TH
    KOIDE, SH
    JOURNAL OF IMMUNOLOGICAL RESEARCH, 1991, 3 (01): : 31 - 36